Hemoglobin (Heme + Globin) is a heterotetramer composed of four polypeptide subunits (2 α and 2 β), each with a prosthetic heme group plus a globin chain. The heme group is formed of a heterocyclic ring, known as a porphyrin which contains an iron (Fe) atom in its center. Usually, the Fe is in the +2 redox state (ferrous) and can reversibly bind oxygen. Each Hb tetramer can bind four oxygen molecules, and 1 g of Hb can combine with 1.39 ml of oxygen (oxygen-binding capacity).

Hemoglobin is the protein contained in red blood cells that is responsible for transporting oxygen from the lungs to the tissues and facilitating the return transport of carbon dioxide. It is an essential protein for all vertebrates and exists in two forms, relaxed (oxygenated) and taut (deoxygenated). The oxygenated form has 300 times more affinity for oxygen than the deoxygenated form. The deoxygenated form promotes release or unloading of oxygen to tissue. The sigmoid shape of the oxygen equilibrium curve shows that hemoglobin exhibits positive cooperativity and negative allostery.

The normal ranges for hemoglobin concentration in adults are for males: 14.0-17.5 (mean 15.7) g/dL, and for females is 12.3-15.3 (mean 13.8) g/dL. When the hemoglobin or the hematocrit is below the lower limit of 2 standard deviations (-2SD) for the normal population, the patient has anemia. Hemoglobin levels above normal may be presented in patients with polycythemia. Polycythemia is characterized by an elevated absolute red blood cell mass, develops from primary or secondary causes. Primary erythrocytosis is used appropriately in the myeloproliferative disorder called polycythemia vera. Whereas, secondary polycythemia generally develops as a response to chronic hypoxia, which triggers increased production of serum erythropoietin (EPO). Secondary erythrocytosis may also be seen in increasing sensitivity to EPO. Common causes of secondary erythrocytosis include smoking, use of androgenic steroids, obstructive sleep apnea, obesity hypoventilation syndrome, and chronic obstructive pulmonary disease (COPD).

Clinical Significance
Approximately 98% of the total oxygen is carried in the blood in reversibly bound to hemoglobin. The blood of a healthy adult human contains at least six different species of hemoglobin molecules, Hemoglobin A (A for adult) makes up 92% of the total hemoglobin concentration. Hb A is composed of two α chains and two β chains, and Hb F (F for fetus) is composed of two α and two γ chains.


Genetic diseases of hemoglobin whose produce abnormal hemoglobins and anemia. According to the pathophysiology, they fall into three main groups:

  • Structural defects in the hemoglobin molecule: sickle hemoglobin is the most common abnormal hemoglobin found in the United States.
  • Hemoglobin chain imbalance: thalassemia syndromes are a group of disorders characterized by a genetic deficiency in the synthesis of normal hemoglobin protein. Chain imbalance in patients with thalassemia syndrome is the crucial factor initiating the damage to RBC, leading to varying degrees of ineffective hematopoiesis and increased hemolysis.
  • Abnormal associations of hemoglobins found in healthy adults: hereditary persistence of fetal hemoglobin (Hb F) is a relatively benign condition, can also be considered as hemoglobinopathy.

Hemoglobinopathies are the most common monogenic diseases around the world, with at least 60, 000 severely affected individuals born every year. Hemoglobin defects are classified as endemic diseases in certain areas, particularly the Mediterranean and Middle Eastern countries. It’s estimated that around 7% of the worldwide population being carriers, and thalassemias (alpha and beta) and the sickling disorders make up the vast majority of cases.

High Yield
What is the difference between allosteric and cooperativity of hemoglobin?

  • Positive cooperativity: there is a cooperative interaction between oxygen binding sites, which means that as oxygenation proceeds, the combination of further molecules of oxygen is made easier.
  • Negative allostery: 2, 3-BPG is a negative allosteric inhibitor, which stabilizes taut (deoxygenated) form, decreasing hemoglobin’s affinity for oxygen.

Which five factors will favor the taut form of hemoglobin, and will decrease affinity for oxygen?
Cl−, H+, CO2, 2,3-BPG, and temperature

To favor oxygen unloading, in what direction is the dissociation curve shifted?
To the right

Before go,

If you enjoyed this article please give it a like and share around on the socials!


  • Mairbäurl H, Weber RE. Oxygen transport by hemoglobin. Compr Physiol. 2012 Apr;2(2):1463-89. doi: 10.1002/cphy.c080113. (link)
  • Rahbar S. Hemoglobin: Structure, function, evolution, and pathology. American Journal of Human Genetics. 1983;35(4):781-782. (link)
  • Pittman RN. Regulation of Tissue Oxygenation. San Rafael (CA): Morgan & Claypool Life Sciences; 2011. Chapter 4, Oxygen Transport. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54103/
  • Marengo-Rowe AJ. Structure-function relations of human hemoglobins. Proceedings (Baylor University Medical Center). 2006;19(3):239-245. (link)
  • McMullin MF. The classification and diagnosis of erythrocytosis. Int J Lab Hematol. 2008 Dec;30(6):447-59. doi: 10.1111/j.1751-553X.2008.01102.x. (link)
  • Marks PW, Glader B. Approach to Anemia in the Adult and Child. Hoffman F, Benz EJ, Shattil SJ, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, PA: Churchill Livingstone; 2009. Chap 34:439-46.
  • Yuan Y, Tam MF, Simplaceanu V, Ho C. A New Look at Hemoglobin Allostery. Chemical reviews. 2015;115(4):1702-1724. doi:10.1021/cr500495x. (link)
  • Strandberg B. Chapter 1: building the ground for the first two protein structures: myoglobin and haemoglobin. J Mol Biol. 2009 Sep 11;392(1):2-10. doi: 10.1016/j.jmb.2009.05.087. (link)
  • Kohne E. Hemoglobinopathies: Clinical Manifestations, Diagnosis, and Treatment. Deutsches Ärzteblatt International. 2011;108(31-32):532-540. doi: 10.3238/arztebl.2011.0532. (link) 
  • Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010 Jun 3;115(22):4331-6. doi: 10.1182/blood-2010-01-251348. (link)
  • Yuan Y, Tam MF, Simplaceanu V, Ho C. A New Look at Hemoglobin Allostery. Chemical reviews. 2015;115(4):1702-1724. doi:10.1021/cr500495x. (link)
  • Thom CS, Dickson CF, Gell DA, Weiss MJ. Hemoglobin Variants: Biochemical Properties and Clinical Correlates. Cold Spring Harbor Perspectives in Medicine. 2013;3(3):a011858. doi:10.1101/cshperspect.a011858. (link)